Company / Capital Returned to Shareholders per Share
Bio-Techne Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$2.06
FY2025
5-year range
$0.59 / $2.54
FY2021-FY2025
Trend
+149.1%
vs FY2024
Sector context
#48 of 108
Health Care
What the data says
At $2.06, Bio-Techne's capital returned to shareholders per share ranks #48 of 108 in the Health Care sector. Capital Returned to Shareholders per Share has fluctuated over the past 10 years, ranging from $0.59 in FY2023 to $2.61 in FY2020.
Based on SEC 10-K filings.
2.06 in FY2025 with a 5-year CAGR of -4.6%.
Improved from $0.59 to $2.06 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -6.7%
- 5-Year CAGR
- -4.6%
- 10-Year CAGR
- -
Sector benchmark
-58.3% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share increased 149.1% year-over-year.
- Ranks #48 out of 108 companies in the Health Care sector.
- Peak capital returned to shareholders per share was recorded in FY2020.
- Lowest capital returned to shareholders per share in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.06 | +149.1% |
| FY2024 | $0.83 | +39.7% |
| FY2023 | $0.59 | -76.7% |
| FY2022 | $2.54 | +53.3% |
| FY2021 | $1.66 | -36.5% |
| FY2020 | $2.61 | +53.9% |
| FY2019 | $1.70 | +34.5% |
| FY2018 | $1.26 | -0.8% |
| FY2017 | $1.27 | -0.9% |
| FY2016 | $1.28 | +0.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026